Mph Jessica L. Mega MD - 03 Jul 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Director
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 03 Jul 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Jul 2023, 16:55:36 UTC
Previous filing: 30 Jun 2023
Next filing: 13 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Award	$0	+3,253		$0.000000	3,253	03 Jul 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of restricted stock vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $174,188.50 (representing the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of common stock on the date of grant.

Content

Grant of restricted stock to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2024 annual meeting of stockholders. The grant of restricted stock vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $174,188.50 (representing the prorated amount of the non-employee director compensation program's annual equity award having a value of $205,000) divided by the closing price of common stock on the date of grant.